(No ratings)
Dr. Minnie Abromowitch, MD is a pediatric oncologist in Omaha, NE specializing in pediatric hematology/oncology. She graduated from University of Manitoba Faculty of Medicine in 1973 and has 51 years of experience. Dr. Minnie Abromowitch, MD is affiliated with Nebraska Medicine.
8200 Dodge Street
Omaha, NE 68114
988102 Nebraska Medical Center
Omaha, NE 68198
Dr. Minnie Abromowitch, MD graduated from University of Manitoba Faculty of Medicine in 1973. She completed residency at The Hospital for Sick Children. She is certified by the Board Certification: Pediatric Hematology Oncology and has a state license in Nebraska.
Medical School: University of Manitoba Faculty of Medicine (1973)
Residency: The Hospital for Sick Children (1976)
Board Certification: Board Certification: Pediatric Hematology Oncology
Licensed In: Nebraska
Dr. Minnie Abromowitch, MD is associated with these hospitals and organizations:
Dr. Minnie Abromowitch, MD does not have any reviews yet, be the first to leave a review of Dr. Minnie Abromowitch, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Minnie Abromowitch, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Jazz Pharmaceuticals Inc. |
$305
Erwinaze $200 |
$105 |
||
---|---|---|---|---|
Novartis Pharmaceuticals Corporation |
$243
VOTRIENT RCC $115 |
JADENU $85 |
PROMACTA $28 |
$15 |
Foundation Medicine, Inc. |
$48
FOUNDATIONONE HEME $48 |
|||
United Therapeutics Corporation |
$13
ORENITRAM $13 |
Food and Beverage | $609 |
---|
Dr. Minnie Abromowitch, MD has received 24 research payments totaling $41,340.
Dr. Minnie Abromowitch is a pediatric hematology/oncology specialist in Omaha, NE. She has indicated that her clinical interests include cancer. Dr. Abromowitch is professionally affiliated with Nebraska Medicine. She obtained her medical school training at the University of Manitoba Faculty of Medicine and performed her residency at The Hospital for Sick Children.